LONGEVERON INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.09 USD | +5.31% |
|
+4.81% | -91.99% |
| Jun. 03 | Longeveron Launches Contract Manufacturing Business | MT |
| Jun. 03 | Longeveron Inc. Announces Initiation of Work Under Its First Manufacturing Services Contract with Secretome Therapeutics | CI |
Chart calendar Longeveron Inc.
7c.oSgjDBX7tajmzuY0l_HrazmjbED6ox6X8mk3Mp1AP10.7H1yW0aM1ue8-dV5wLikPQvAXBTO-VH6iAR_XM4OaCTPYRJNVrXazaj_gQ~66bd882a890a715e314b5b0765145b71
Upcoming events on Longeveron Inc.
Past events on Longeveron Inc.
| 2024-05-14 05:00 pm | Q1 2024 Earnings Call |
| 2024-05-14 04:05 pm | Q1 2024 Earnings Release |
| 2024-05-01 07:30 pm | Planet MicroCap Conference |
| 2024-02-27 05:00 pm | Q4 2023 Earnings Call |
| 2024-02-27 04:05 pm | Q4 2023 Earnings Release |
| 2024-02-21 01:00 pm | Extraordinary Shareholders Meeting |
| 2023-12-26 11:00 am | Extraordinary Shareholders Meeting |
| 2023-11-10 08:30 am | Q3 2023 Earnings Call |
| 2023-11-10 07:30 am | Q3 2023 Earnings Release |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-09-05 | Emerging Growth Conference |
| 2023-09-05 | National Investment Banking Association Conference |
| 2023-08-16 10:00 am | Investor Meeting - Key Opinion Leader |
| 2023-08-11 08:00 am | Q2 2023 Earnings Call |
| 2023-08-11 08:00 am | Q2 2023 Earnings Release |
| 2023-08-09 10:15 am | Emerging Growth Conference |
| 2023-06-09 01:00 pm | Annual General Meeting |
| 2023-05-12 08:30 am | Q1 2023 Earnings Call |
| 2023-05-12 08:00 am | Q1 2023 Earnings Release |
| 2023-03-10 08:30 am | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,63 | 1,31 1,30 0.46% | 1,22 1,15 6.21% | 0,71 0,71 -0.28% | 1,65 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -16,5 -8,90 -85.87% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -17,5 -18,3 4.61% | -18,0 -18,3 1.65% | -21,0 -20,4 -3.07% | -21,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -18,8 -19,9 5.45% | -21,4 -20,2 -6.01% | -21,2 |
|
Net income Million USD | Released Forecast Spread | -3,72 | -17,0 -17,8 4.24% | -18,8 -19,9 5.45% | -21,4 -20,6 -3.96% | -21,2 |
|
EPS USD | Released Forecast Spread | 0,00 | -9,00 -9,45 4.76% | -9,00 -8,70 -3.45% | -10,2 -9,50 -7.37% | -4,47 |
| Announcement Date | 30/03/21 | 11/03/22 | 10/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,37 0,25 48% | 0,47 0,20 133% | 0,27 0,10 165% | 0,12 0,20 -39.5% | 0,28 0,15 86% | 0,22 0,20 8.5% | 0,15 0,27 -43.4% | 0,06 0,07 -3.08% | 0,55 0,06 813.33% | 0,36 | 0,38 | 0,39 | 0,40 | 0,40 |
|
EBITDA Million USD | Released Forecast Spread | -3,21 -2,60 -23.31% | -3,30 -2,90 -13.69% | ||||||||||||
|
EBIT Million USD | Released Forecast Spread | -3,39 -5,10 33.45% | -4,22 -3,96 -6.48% | -5,19 -4,65 -11.5% | -5,24 -5,54 5.48% | -4,72 | -5,71 -4,63 -23.46% | -5,16 -5,16 -0.11% | -5,44 -4,81 -13.02% | -4,09 -5,01 18.34% | -4,66 | -4,83 | -5,01 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,62 -3,96 -41.88% | -5,24 -4,65 -12.73% | -4,46 -5,54 19.61% | -4,65 | -5,63 -5,03 -11.92% | -5,11 -5,12 0.35% | -6,03 -4,81 -25.23% | -4,06 -4,79 15.28% | -5,23 | -5,61 | -6,29 | |||
|
Net income Million USD | Released Forecast Spread | -3,51 -5,10 31.18% | -5,62 -3,96 -41.88% | -5,24 -4,65 -12.73% | -4,46 -5,54 19.61% | -4,65 | -5,63 -5,29 -6.4% | -5,90 -5,18 -13.89% | -6,03 -4,81 -25.23% | -4,06 -5,01 18.98% | -4,66 | -4,83 | -5,01 | ||
|
EPS USD | Released Forecast Spread | -1,70 -2,25 24.44% | -2,70 -2,27 -19.12% | -2,50 -2,20 -13.64% | -2,10 -2,00 -5% | -2,20 -2,25 2.22% | -2,70 -2,47 -9.46% | -2,80 -2,40 -16.67% | -2,50 -2,05 -21.95% | -1,61 -2,01 19.7% | -1,36 | -1,17 | -0,94 | -1,00 | -1,00 |
| Announcement Date | 13/05/22 | 12/08/22 | 14/11/22 | 10/03/23 | 12/05/23 | 11/08/23 | 09/11/23 | 27/02/24 | 14/05/24 | - | - | - | - | - |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Longeveron Inc.
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LGVN Stock
- Calendar Longeveron Inc.
